Rabian

Rabian BV is an innovative Dutch SME in the field of infectious diseases, founded in 2023 by a multidisciplinary team of experienced entrepreneurs and world-leading scientists with extensive backgrounds in immunology, virology, and commercialization. Our mission is to develop cost-effective vaccines and post-exposure treatments for diseases with endemic and pandemic potential. Rabian aims to become a leading developer of cost-effective vaccines and preventive therapies for endemic infectious diseases.